Furthermore, as tumor growth progresses, both mouse and human NK cells exhibit decreased expression of the degranulation marker CD107a (29, 36, 131), as well as decreased IFNγ (29, 131) and perforin (36, 131) (Figure 3). The gene discussed is IFNG; the disease is neoplasm.